InvestorsHub Logo
Followers 276
Posts 32701
Boards Moderated 0
Alias Born 11/14/2013

Re: cntmein post# 5459

Friday, 03/07/2014 12:14:00 PM

Friday, March 07, 2014 12:14:00 PM

Post# of 701090
Not quite.

IMHO, the data safety monitoring board still has the 1st interim analysis under review for efficacy. They can't take a look at any new data for probability until the 2nd interim analysis. Therefore, they are still reviewing efficacy with the data they have. This is the way sequential analysis works. You cannot peak at probability data inbetween the 1st and 2nd analysis.

Consequently, if you take the PR at face value, they are still considering efficacy with the present (66 events) data set.
"Review of the efficacy data is still pending"

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News